Dorsal Root Ganglia Homeobox (DRGX) Peptide
DRGX
Reactivity: Mammalian
Host: Synthetic
BP, WB, IHC
-
- Target See all DRGX products
- DRGX (Dorsal Root Ganglia Homeobox (DRGX))
- Peptide Type
- Synthetic
- Origin
- Mammalian
-
Source
- Synthetic
- Application
- Blocking Peptide (BP), Western Blotting (WB), Immunohistochemistry (IHC)
- Sequence
- KEPMAEVTPP PVRNINSPPP GDQARSKKEA LEAQQSLGRT VGPAGPFFPS
- Characteristics
-
A synthetic peptide for use as a blocking control in assays to test for specificity of DRGX antibody,
Alternative Names: DRGX control peptide, DRGX antibody Blocking Peptide, Anti-DRGX Blocking Peptide, dorsal root ganglia homeobox Blocking Peptide, DRG11 Blocking Peptide, PRRXL1 Blocking Peptide
-
-
- Application Notes
- Optimal conditions should be determined by the investigator
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Reconstitution
- Add 100 µL of distilled water for a final peptide concentration is 1 mg/mL.
- Buffer
- PBS
- Handling Advice
- Avoid repeated freeze/thaw cycles.
- Storage
- -20 °C
- Storage Comment
- Store at -20 °C long term.
-
- Target
- DRGX (Dorsal Root Ganglia Homeobox (DRGX))
- Background
- DRGX is a transcription factor required for the formation of correct projections from nociceptive sensory neurons to the dorsal horn of the spinal cord and normal perception of pain.
- Molecular Weight
- 29 kDa
-
You are here:
